Table 1.
IncobotulinumtoxinA doses administered, treatment patterns and injected muscles in the MP and OLEX
Units (high dose, 400 U) | Units (low dose, 250 U) | mLa | Number of injection sitesa | |
---|---|---|---|---|
MP: Upper-limb treatment, with treatment of thumb-in-palm | ||||
Flexed wrist | 100 | 62.50 | 2.0 | – |
Flexor carpi radialisb | 50 | 31.25 | 1.0 | 1–2 |
Flexor carpi ulnarisb | 50 | 31.25 | 1.0 | 1–2 |
Clenched fist | 100 | 62.50 | 2.0 | – |
Flexor digitorum superficialisb | 50 | 31.25 | 1.0 | 1–2 |
Flexor digitorum profundusb | 50 | 31.25 | 1.0 | 1–2 |
Flexed elbow and pronated forearm | 150 | 93.75 | 3.0 | – |
Bicepsb | 100 | 62.50 | 2.0 | 2–4 |
Pronator teresb | 50 | 31.25 | 1.0 | 1–2 |
Thumb-in-palm | 50 | 31.25 | 1.0 | – |
Flexor pollicis longusb | 20 | 12.50 | 0.4 | 1 |
Adductor pollicisb | 20 | 12.50 | 0.4 | 1 |
Flexor pollicis brevis or opponens pollicisb | 10 | 6.25 | 0.2 | 1 |
MP: Upper-limb treatment, without treatment of thumb-in-palm | ||||
Flexed wrist | 100 | 62.50 | 2.0 | – |
Flexor carpi radialisb | 50 | 31.25 | 1.0 | 1–2 |
Flexor carpi ulnarisb | 50 | 31.25 | 1.0 | 1–2 |
Clenched fist | 100 | 62.50 | 2.0 | – |
Flexor digitorum superficialisb | 50 | 31.25 | 1.0 | 1–2 |
Flexor digitorum profundusb | 50 | 31.25 | 1.0 | 1–2 |
Flexed elbow and pronated forearm | 200 | 125.00 | 4.0 | – |
Bicepsb | 100 | 62.50 | 2.0 | 2–4 |
Brachialisb | 50 | 31.25 | 1.0 | 1–2 |
Pronator teresb | 50 | 31.25 | 1.0 | 1–2 |
OLEX: Upper-limb treatment | Unitsc | mLc | Number of injection sitesa |
---|---|---|---|
Flexed wrist | – | ||
Flexor carpi radialisd | 25–100 | 0.5–2.0 | 1–2 |
Flexor carpi ulnarisd | 20–100 | 0.4–2.0 | 1–2 |
Clenched fist | – | – | – |
Flexor digitorum superficialisd | 25–100 | 0.5–2.0 | 1–2 |
Flexor digitorum profundusd | 25–100 | 0.5–2.0 | 1–2 |
Flexed elbow and pronated forearm | – | – | – |
Brachioradialisd | 25–100 | 0.5–2.0 | 1–3 |
Bicepsd | 50–200 | 1.0–4.0 | 2–4 |
Brachialisd | 25–100 | 0.5–2.0 | 1–2 |
Pronator quadratusd | 10–50 | 0.2–1.0 | 1 |
Pronator teresd | 25–75 | 0.5–1.5 | 1–2 |
If thumb spasticity is presentc | – | – | – |
Flexor pollicis longus | 10–50 | 0.2–1.0 | 1 |
Adductor pollicis | 5–30 | 0.1–0.6 | 1 |
Flexor pollicis brevis or opponens pollicis | 5–30 | 0.1–0.6 | 1 |
MP main period; OLEX open-label extension
aMaximum 1.0 mL per injection site
bInjection of all these muscles is mandatory
cIf muscle is chosen for injection. For muscles not requiring treatment, 0 U/mL might be applicable
d400 U dose distribution at the investigator’s discretion